Source: Clinical Trials Arena

Arctic Vision: Arctic Vision starts dosing with ARVN001 in macular oedema trial

The post Arctic Vision starts dosing with ARVN001 in macular oedema trial appeared first on Clinical Trials Arena.

Read full article »
Arctic Vision's Competitors | Arctic Vision's News | Arctic Vision's Financials
Stay up-to-date with the latest news on Arctic Vision
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Eddy Wu's photo - Founder & CEO of Arctic Vision

Founder & CEO

Eddy Wu

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Arctic Vision